Home » Topics » BioWorld Science

BioWorld Science
RSS

Chengdu Fanxi Biopharma discovers thyroid hormone receptor alpha/beta agonists

March 14, 2022

New Bruton tyrosine kinase inhibitors identified at Beijing Innocare Medical Technology

March 14, 2022

TYK2 inhibitors described by Ennovabio (Zhejiang) Pharmaceuticals, Shanghai Ennova Biopharmaceutical

March 14, 2022

Blocking UBE2N evades oncogenic immune signaling in AML

March 14, 2022

Sensei advances preclinical pipeline based on TMAb and ImmunoPhage platforms

March 11, 2022

Poseida Therapeutics reports progress across nonclinical programs

March 11, 2022

Morningside Ventures launches Adiso Therapeutics focused on inflammatory diseases

March 11, 2022

AEterna Zentaris expands research agreement with JMU to support COVID-19 and Chlamydia vaccines

March 11, 2022

Oncternal advances ONCT-808 toward IND filing and ONCT-534 into IND-enabling studies

March 11, 2022

STK-002 enters preclinical toxicology studies for autosomal dominant optic atrophy

March 11, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 8, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.